| Literature DB >> 32047525 |
Virág Demján1,2,3, Tivadar Kiss2,4, Andrea Siska5, Márton Richárd Szabó1,2,3, Márta Sárközy1,2,3, Imre Földesi5, Dezső Csupor2,4, Tamás Csont1,2,3.
Abstract
BACKGROUND: In folk medicine, common chickweed (Stellaria media) has traditionally been applied for the treatment of hypercholesterolemia; however, there is no firm experimental proof to support the rationale of this practice. Therefore, we aimed to assess the efficacy and safety of Stellaria media) has traditionally been applied for the treatment of hypercholesterolemia; however, there is no firm experimental proof to support the rationale of this practice. Therefore, we aimed to assess the efficacy and safety of Materials and Methods. Adult male Wistar rats were divided into 3 groups. The (i) control group received standard laboratory chow, the (ii) hypercholesterolemic group received cholesterol-enriched diet, and the (iii) chickweed-treated hypercholesterolemic group received cholesterol-enriched diet and 100 mg/kg body weight Stellaria media) has traditionally been applied for the treatment of hypercholesterolemia; however, there is no firm experimental proof to support the rationale of this practice. Therefore, we aimed to assess the efficacy and safety of.Entities:
Year: 2020 PMID: 32047525 PMCID: PMC7003252 DOI: 10.1155/2020/5109328
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1Body weight (a) and weight gain after 8 weeks (b) in the control group (white spheres) and rats fed with cholesterol-enriched diet (black triangles) or cholesterol-enriched diet with Stellaria media extract (grey squares). Results are means ± SEM (n = 8 in each group), analyzed by one-way ANOVA with Tukey post hoc test.
Figure 2Serum total cholesterol (a), serum triacylglycerol (b), LDL cholesterol (c), and HDL cholesterol (d) levels in rats fed either cholesterol-enriched (HChol), cholesterol-enriched + Stellaria media (HChol + SM), or normal diet (Cont). Results are means ± SEM (n = 8 in each group), analyzed by one-way ANOVA with the Tukey post hoc test. p < 0.05 vs. control, p < 0.01 vs. control.
Figure 3Liver weight (a), serum total protein levels (b), albumin levels (c), alkaline phosphatase (ALP) activity (d), alanine aminotransferase (ALT) activity (e), and aspartate aminotransferase (AST) activity (f) in rats fed either cholesterol-enriched (HChol), cholesterol-enriched + Stellaria media (HChol + SM), or normal diet (Cont). Results are means ± SEM (n = 8 in each group), analyzed by one-way ANOVA with the Tukey post hoc test. p < 0.05 vs. control, p < 0.01 vs. control.
Figure 4Serum carbamide (a) and creatinine (b) levels in rats fed either cholesterol-enriched (HChol), cholesterol-enriched + Stellaria media (HChol + SM), or normal diet (Cont). Results are means ± SEM (n = 8 in each group), analyzed by one-way ANOVA with the Tukey post hoc test.
Effects of Stellaria media on left ventricular morphological and functional parameters. Transthoracic echocardiographic measurement values in rats fed either cholesterol-enriched (HChol), cholesterol-enriched + Stellaria media (HChol + SM), or normal diet (Cont). Results are means ± SEM (n = 8 in each group), analyzed by one-way ANOVA with the Tukey post hoc test. 2D: two dimensional; 4CH: four chambers view; MM: M (motion) Mode; ns: not significant.
| Parameter (unit) | View/mode | Week 8 | Significance | ||
|---|---|---|---|---|---|
| Cont | HChol | HChol + SM | |||
| Anterior wall thickness-systolic (mm) | Short axis/MM | 3.57 ± 0.11 | 3.41 ± 0.17 | 3.10 ± 0.12 | ns |
| Anterior wall thickness-diastolic (mm) | Short axis/MM | 2.20 ± 0.11 | 2.22 ± 0.17 | 2.16 ± 0.11 | ns |
| Inferior wall thickness-systolic (mm) | Short axis/MM | 3.85 ± 0.11 | 3.46 ± 0.15 | 3.69 ± 0.09 | ns |
| Inferior wall thickness-diastolic (mm) | Short axis/MM | 2.14 ± 0.09 | 2.13 ± 0.14 | 2.19 ± 0.13 | ns |
|
| |||||
| Posterior wall thickness-systolic (mm) | Long axis/MM | 3.82 ± 0.08 | 3.68 ± 0.12 | 3.62 ± 0.09 | ns |
| Posterior wall thickness-diastolic (mm) | Long axis/MM | 2.19 ± 0.03 | 2.39 ± 0.13 | 2.52 ± 0.19 | ns |
| Septal wall thickness-systolic (mm) | Long axis/MM | 3.79 ± 0.06 | 3.62 ± 0.12 | 3.54 ± 0.17 | ns |
| Septal wall thickness-diastolic (mm) | Long axis/MM | 2.50 ± 0.11 | 2.24 ± 0.10 | 2.35 ± 0.11 | ns |
|
| |||||
| Left ventricular end-diastolic volume ( | 4CH/2D | 127 ± 15 | 129 ± 13 | 105 ± 13 | ns |
| Left ventricular end-systolic volume ( | 4CH/2D | 49 ± 8 | 53 ± 5 | 46 ± 6 | ns |
| Stroke volume ( | 4CH/2D | 79 ± 8 | 76 ± 8 | 59 ± 8 | ns |
| Ejection fraction (%) | 4CH/2D | 63 ± 2 | 59 ± 1 | 56 ± 3 | ns |
| Heart rate (1/min) | 4CH/2D | 343 ± 14 | 367 ± 8 | 370 ± 11 | ns |